| Literature DB >> 33437791 |
Yuan Li1, Xiao-Meng Zhang1, Shu-Jiao Qian1, Shi-Chong Qiao1, Hong-Chang Lai1, Jun-Yu Shi1.
Abstract
BACKGROUND: This study aimed to explore the influence of initial ridge defect morphology on the outcome of guided bone regeneration (GBR) in the anterior maxilla region.Entities:
Keywords: Initial ridge defect morphology; cone beam computed tomography (CBCT); guided bone regeneration (GBR); morphological contour interpolation (MCI)
Year: 2020 PMID: 33437791 PMCID: PMC7791218 DOI: 10.21037/atm-20-1432
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 13D surface rendering of bone grafts at T0 (A) and T1 (D) were reconstructed based on original CBCT data. The change of the whole bone grafts could be visible. (B,E) frontal view of bone grafts at T0 and T1; (C,F) lateral view of bone grafts at T0 and T1.
Figure 2The initial bone defect was reconstructed, and the initial defect morphology was defined on mesial-distal, coronal-apical, and buccal-lingual dimension. (A) Preoperative CBCT reconstruction image; (B) 3D surface rendering of initial bone defect obtained using a mirror image of the contralateral alveolar ridge; (C) 3D surface rendering of initial bone defect was divided into slices in 0.25 mm from mesial to distal (S1, S2 to Sn) at the sagittal plane and from coronal to apical (H1, H2 to Hn) at the horizontal plane. Intersection points of slices in sagittal and horizontal planes were marked on the outer surface of 3D surface rendering; (D) intersection points on the outer surface were projected onto the inner surface. The length of projection lines was considered as the buccal-lingual distance of bone defect.
Summary of patient characteristics
| Characteristics | Values |
|---|---|
| Age (years), mean (SD) | 30.9 (9.1) |
| Male/female | 36/26 |
| Type of membrane: Bio-Gide®/Zhenghai® | 34/28 |
| Implant site: I1/I2/C | 32/22/8 |
| Implant diameter: 3.3 mm/4.1 mm | 28/34 |
| Implant length: 10 mm/12 mm | 24/38 |
I1, central incisor; I2, lateral incisor; C, canine.
Radiographic data of grafted bone around implants with linear and volumetric measurements in median (IQR) at various time points and levels
| Measurements | Test group (n=28) | Control group (n=34) | LCB or VCB (%) | |||||
|---|---|---|---|---|---|---|---|---|
| T0 | T1 | LCB or VCB (%) | T0 | T1 | LCB or VCB (%) | |||
| Linear measurement: the thickness of facial bone wall (TBW, mm) | ||||||||
| 2 mm level | 2.78 (2.06–3.02) | 2.07 (1.80–2.51) | 19.25 (2.91–40.89) | 2.36 (1.98–2.82) | 1.92 (1.45–2.36) | 18.14 (4.27–31.33) | 18.68 (2.91–36.11) | |
| 4 mm level | 2.95 (2.60–4.10) | 2.51 (2.37–3.14) | 17.25 (2.37–31.05) | 3.03 (2.45–3.44) | 2.43 (1.90–2.95) | 21.13 (16.89–28.84) | 19.77 (6.45–28.84) | |
| 6 mm level | 3.35 (2.82–4.30) | 2.67 (2.25–3.08) | 15.19 (8.11–29.53) | 3.46 (2.78–4.17) | 2.60 (1.97–3.21) | 24.76 (18.90–34.88) | 17.24 (4.72–33.33) | |
| Volumetric measurement: volume of bone grafts (VBG, mm3) | 386.15 (334.11–453.19) | 169.70 (118.26–301.72) | 49.55 (31.80–60.00) | 363.05 (289.17–573.35) | 221.35 (159.01–275.05) | 52.00 (28.30–55.00) | 52.00 (28.30–59.80) | |
Test group: patients treated with bovine dermis-derived collagen membrane; Control group: patients treated with Bio-Gide®. LCB: Linear change of bone grafts = TBWT0 − TBWT1/TBWT0 × 100%; VCB: Volumetric change of bone grafts = VBGT0 − VBGT1/VBGT0 × 100%. The Mann-Whitney test showed that no significant difference was found in LCB at identical measurement level or VCB between two groups.
Spearman correlation coefficients for the predictive variables and bone graft resorption rate for the total sample
| Variables | Volumetric changes of bone grafts (%) | |
|---|---|---|
| r | P value | |
| Gender | −0.091 | 0.480 |
| Age | −0.088 | 0.495 |
| Membrane | −0.130 | 0.312 |
| Implant site | −0.242 | 0.078 |
| mCA | 0.274 | 0.031 |
| mMD | −0.425 | <0.001 |
| mBL | −0.380 | 0.002 |
| BLMean | −0.280 | 0.027 |
| BLSD | −0.315 | 0.013 |
| Ratio of mCA/mMD | 0.607 | <0.001 |
| Ratio of mCA/mBL | 0.497 | <0.001 |
| Ratio of mBL/mMD | 0.136 | 0.292 |
Baseline demographic and initial defect morphological variables are classified according to the median of VCB
| Variables | Group 1 (VCB ≥52.0%) | Group 2 (VCB <52.0%) | P values |
|---|---|---|---|
| Demographic variables | |||
| Age (years), mean ± SD | 30.3±10.0 | 31.5±8.3 | 0.602 |
| Male, n/total, n (%) | 17/31 (54.8) | 19/31 (61.3) | 0.606 |
| Female, n/total, n (%) | 14/31 (45.2) | 12/31 (38.7) | |
| Type of membrane, n/total, n (%) | |||
| Bio-Gide® | 18/31 (58.1) | 16/31 (51.6) | 0.610 |
| Zhenghai® | 13/31 (41.9) | 15/31 (48.3) | |
| Implant site*, n/total, n (%) | |||
| Central incisor | 17/23 (73.9) | 15/31 (48.4) | 0.059 |
| Lateral incisor | 6/23 (26.1) | 16/31 (51.6) | |
| Initial defect morphological variables, median (IQR) | |||
| BLMean | 3.17 (2.70–3.44) | 3.49 (2.87–4.24) | 0.043 |
| BLSD | 0.89 (0.78–1.06) | 1.07 (0.84–1.32) | 0.028 |
| mCA | 8.75 (7.50–9.38) | 7.50 (6.25–10.0) | 0.180 |
| mMD | 8.75 (7.50–10.63) | 10.00 (10.00–13.75) | 0.002 |
| mBL | 4.93 (4.36–5.53) | 6.11 (4.86–7.03) | 0.006 |
| Ratio of mCA/mMD | 0.94 (0.78–1.08) | 0.67 (0.58–0.89) | <0.001 |
| Ratio of mCA/mBL | 1.70 (1.31–2.07) | 1.31 (0.95–1.54) | 0.001 |
| Ratio of mBL/mMD | 0.57 (0.46–0.72) | 0.55 (0.49–0.63) | 0.617 |
*, 8 records with canines were deleted because of the small sample size.
Figure 3Morphological variables for prediction of VCB. Receiver-operating characteristic curve (ROC) analysis as assessed according to the median of VCB (≥52.00% or <52.00%). VCB, volumetric change of bone grafts; AUC, areas under curve.